Key Metrics
Eigenfactor 

< 0.001
Impact Factor 

< 5
Recommended pre-submission checks
Powered by 

Topics Covered on JOURNAL OF HEPATOCELLULAR CARCINOMA
JOURNAL OF HEPATOCELLULAR CARCINOMA Journal Specifications
Indexed in the following public directories
Web of Science
DOAJ
SJR
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2836 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in JOURNAL OF HEPATOCELLULAR CARCINOMA ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in JOURNAL OF HEPATOCELLULAR CARCINOMA
Identification of a Prognostic Gene Signature Based on Lenvatinib Resistance in Hepatocellular Carcinoma with Functional Validation of the Key Gene CPB2
- 14 May 2026
- Journal of Hepatocellular Carcinoma
USP9X Promotes Hepatocellular Carcinoma Progression via Stabilization of HSP90AA1
- 12 May 2026
- Journal of Hepatocellular Carcinoma
A Reproducible MRI-Based Quantitative Feature for Differentiating Dysplastic Nodules from Hepatocellular Carcinoma: A Multicenter Retrospective Study
- 12 May 2026
- Journal of Hepatocellular Carcinoma
Liver Transplantation After Radiotherapy-Antiangiogenesis-Immune Checkpoint Blockade Combination Therapy in Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Propensity Score Matching Analysis
- 8 May 2026
- Journal of Hepatocellular Carcinoma
ADAM12 Stabilizes EIF3B to Promote Glycolysis and Tumor Progression in Hepatocellular Carcinoma.
- 1 May 2026
- Journal of hepatocellular carcinoma
GRB2 Promotes Sorafenib Resistance in Hepatocellular Carcinoma Cells Under Hypoxia by Activating the PI3K/AKT Signaling Pathway.
- 1 May 2026
- Journal of hepatocellular carcinoma
Identification of a Prognostic Gene Signature Based on Lenvatinib Resistance in Hepatocellular Carcinoma with Functional Validation of the Key Gene CPB2
- 14 May 2026
- Journal of Hepatocellular Carcinoma
USP9X Promotes Hepatocellular Carcinoma Progression via Stabilization of HSP90AA1
- 12 May 2026
- Journal of Hepatocellular Carcinoma
A Reproducible MRI-Based Quantitative Feature for Differentiating Dysplastic Nodules from Hepatocellular Carcinoma: A Multicenter Retrospective Study
- 12 May 2026
- Journal of Hepatocellular Carcinoma
Liver Transplantation After Radiotherapy-Antiangiogenesis-Immune Checkpoint Blockade Combination Therapy in Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Propensity Score Matching Analysis
- 8 May 2026
- Journal of Hepatocellular Carcinoma
ADAM12 Stabilizes EIF3B to Promote Glycolysis and Tumor Progression in Hepatocellular Carcinoma.
- 1 May 2026
- Journal of hepatocellular carcinoma
GRB2 Promotes Sorafenib Resistance in Hepatocellular Carcinoma Cells Under Hypoxia by Activating the PI3K/AKT Signaling Pathway.
- 1 May 2026
- Journal of hepatocellular carcinoma